SELLAS Life Sciences GAAP EPS of -$0.34 beats by $0.05

Nov. 14, 2022 8:28 AM ETSELLAS Life Sciences Group, Inc. (SLS)By: Meghavi Singh, SA News Editor
  • SELLAS Life Sciences press release (NASDAQ:SLS): Q3 GAAP EPS of -$0.34 beats by $0.05.
  • As of September 30, 2022, cash and cash equivalents totaled approximately $21.3M.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.